Advanced BioScience Laboratories Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Advanced BioScience Laboratories Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3395
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Advanced BioScience Laboratories Inc (ABL), a subsidiary of Institut Merieux SA is a contract manufacturing company that provides contract manufacturing and laboratory research services to advance leading vaccines and therapies from clinical development to the commercial market. The company develops therapeutics, vaccines, and other biologic products. It provides proof-of-concept in vivo studies with potency testing, preclinical immunomonitoring, and efficacy. ABL’s services include upstream cell culture, technology transfer, contract research services and contract manufacturing services. The company’s contract research and contract manufacturing services include cGMP virus banking, virus seed stock development, plaque purification, viral lysate production, downstream purification development, production of toxicology supply, upstream process development, and production of clinical supply. ABL is headquartered in Rockville, Maryland, the US.

Advanced BioScience Laboratories Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Advanced BioScience Laboratories Inc, Medical Devices Deals, 2012 to YTD 2018 9
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Advanced BioScience Labs Acquires Production Asset of Transgene 11
Partnerships 12
ABL Enters into Development Agreement with Najit Technologies 12
ABL Enters into Contract Manufacturing Agreement with RegenxBio 13
Advanced BioScience Enters Into Co-Marketing Agreement With Calixar 14
Asset Transactions 15
Bioqual Completes Acquisition Of In-Vivo Animal Model Services Related Assets From ABL 15
Advanced BioScience Laboratories Inc – Key Competitors 17
Advanced BioScience Laboratories Inc – Key Employees 18
Advanced BioScience Laboratories Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Strategy And Business Planning 20
May 11, 2017: ABL Increases Aseptic Fill/Finish Capacity with State-of-the-Art, Fully Automated Vial Filling Line 20
Corporate Communications 21
Jun 04, 2018: ABL Announces Hiring of Marykay Marchigiani as Chief Financial Officer 21
Other Significant Developments 22
Sep 26, 2017: Aushon BioSystems and ABL Announce Adoption of the Cira Platform for Multiplex and Ultrasensitive Biomarker Testing 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Key Facts 2
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advanced BioScience Laboratories Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Advanced BioScience Laboratories Inc, Medical Devices Deals, 2012 to YTD 2018 9
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Advanced BioScience Labs Acquires Production Asset of Transgene 11
ABL Enters into Development Agreement with Najit Technologies 12
ABL Enters into Contract Manufacturing Agreement with RegenxBio 13
Advanced BioScience Enters Into Co-Marketing Agreement With Calixar 14
Bioqual Completes Acquisition Of In-Vivo Animal Model Services Related Assets From ABL 15
Advanced BioScience Laboratories Inc, Key Competitors 17
Advanced BioScience Laboratories Inc, Key Employees 18
Advanced BioScience Laboratories Inc, Subsidiaries 19

List of Figures
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Advanced BioScience Laboratories Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Advanced BioScience Laboratories Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Core-Mark Holding Company, Inc. (CORE):企業の財務・戦略的SWOT分析
    Core-Mark Holding Company, Inc. (CORE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Nomura Holdings, Inc.:企業の戦略・SWOT・財務情報
    Nomura Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nomura Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • AcelRx Pharmaceuticals Inc (ACRX)-医療機器分野:企業M&A・提携分析
    Summary AcelRx Pharmaceuticals Inc (AcelRx), is a specialty pharmaceutical company that develops and commercializes novel therapies for the treatment of pain. The company’s lead product candidate, DSUVIA (known as ARX-04 outside the US), is a single sufentanil sublingual tablet for the treatment of …
  • MAN Diesel & Turbo SE-エネルギー分野:企業M&A・提携分析
    Summary MAN Diesel & Turbo SE (MAN Diesel), a subsidiary of MAN SE, is a large-bore diesel engines and turbomachinery provider. Its product portfolio includes turbochargers, propellers, gas engines and chemical reactors; and goods include marine propulsion systems, turbomachinery units for oil and g …
  • Chatham Lodging Trust:企業の戦略・SWOT・財務情報
    Chatham Lodging Trust - Strategy, SWOT and Corporate Finance Report Summary Chatham Lodging Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Reliance Steel & Aluminum Co:企業の戦略・SWOT・財務分析
    Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report Summary Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Calimmune Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Calimmune Inc (Calimmune), a subsidiary of CSL Behring Australia Pty Ltd, is a novel gene therapy program developer. The company’s ex vivio autulogus cell therapy includes CAL-1 and CAL-H. Its CAL-1 offers cell therapies for HIV AIDS. Calimmune’s CAL-H cell therapy provides himoglobinopathie …
  • Immune Pharmaceuticals Inc (IMNP):企業の財務・戦略的SWOT分析
    Summary Immune Pharmaceuticals Inc (Immune Pharma), formerly EpiCept Corp is a drug development company that develops novel therapies for immunologic and inflammatory diseases. The company’s pipeline products include Bertilimumab and Nanocyclo. Its Bertilimumab is a human monoclonal antibody designe …
  • Fortis Healthcare Ltd (FORTIS):製薬・医療:M&Aディール及び事業提携情報
    Summary Fortis Healthcare Ltd (Fortis) is an integrated healthcare provider that delivers healthcare services in the Pan Asia-Pacific region. The company’s services portfolio comprises diagnostics, primary care, day care and specialty hospitals. It owns, operates, and manages a chain of multi-specia …
  • Euronav NV (EURN):企業の財務・戦略的SWOT分析
    Summary Euronav NV (Euronav) is a transportation and logistics company that offers shipping services. The company provides sea-borne transportation, tanker shipping, proactive management, fleet composition and ship management services, among others. It offers ship management services which includes …
  • Crrc Corporation Limited:企業の戦略・SWOT・財務分析
    Crrc Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Crrc Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • GSI Technology, Inc. (GSIT):企業の財務・戦略的SWOT分析
    GSI Technology, Inc. (GSIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Quanta Services Inc (PWR):石油・ガス:M&Aディール及び事業提携情報
    Summary Quanta Services, Inc. (Quanta) is a specialized contracting services company that offers infrastructure solutions. It designs, installs, upgrades, repairs and maintains infrastructure of electric power transmission and distribution networks, substation facilities, renewable energy facilities …
  • Severn Glocon Group Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Severn Glocon Group Plc (Severn Glocon), formerly Sageshire Ltd is a designer and manufacturer of engineered valve products. The company offers control, choke, and subsea valves; small bore subsea valves and actuators; filters and dryers; low-friction valve actuators, engineered valves, meta …
  • Nexstar Media Group, Inc. (NXST):企業の財務・戦略的SWOT分析
    Nexstar Media Group, Inc. (NXST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Great Western Oil & Gas Co LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Great Western Oil & Gas Co LLC (GWOG), a subsidiary of The Broe Group, is an oil and gas company that offers exploration and production of oil and gas properties. The company operates through developmental drilling, and corporate and property acquisition operations. Its core area of operatio …
  • Indiana Municipal Power Agency:電力:M&Aディール及び事業提携情報
    Summary Indiana Municipal Power Agency (IMPA) is a not-for-profit wholesale power provider supplying power to cities and communities across Indiana and Ohio. The agency was formed by its member utilities which enable them to share power resources and provide electricity economically to their custome …
  • Molecular Templates Inc:企業のM&A・事業提携・投資動向
    Molecular Templates Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Molecular Templates Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Jadranka dd:企業の戦略・SWOT・財務分析
    Jadranka dd - Strategy, SWOT and Corporate Finance Report Summary Jadranka dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Toagosei Co., Ltd.:企業の戦略・SWOT・財務分析
    Toagosei Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Toagosei Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆